- Patent Title: Lithium salts of N-substituted glycine compounds and uses thereof
-
Application No.: US15646034Application Date: 2017-07-10
-
Publication No.: US10226442B2Publication Date: 2019-03-12
- Inventor: Guochuan Emil Tsai , Ching-Hsun Huang , Han-Yi Hsieh , Jing-Jia Huang , Ching-Cheng Wang
- Applicant: SyneuRx International (Taiwan) Corp.
- Applicant Address: TW New Taipei
- Assignee: SyneuRx International (Taiwan) Corp.
- Current Assignee: SyneuRx International (Taiwan) Corp.
- Current Assignee Address: TW New Taipei
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A23L33/00
- IPC: A23L33/00 ; A23L33/16 ; A61K31/12 ; A61K31/40 ; A61K45/06 ; A61K31/198 ; A61K31/382 ; A61K31/407 ; A61K31/496 ; A61K31/519 ; A61K31/554 ; A61K31/4439 ; A61K31/5415 ; A61K31/5513
Abstract:
The present invention relates to a composition comprising a lithium salt of an N-substituted glycine compound and a carrier, wherein the lithium salt of the N-substituted glycine compound is of Formula (I): in which R1, R2, and R3 each are independently hydrogen, alkyl, alkenyl, alkynyl, aralkyl, carbocyclyl, aryl, or heteroaryl, or one of R1, R2, and R3 is absent. Also provided in the present invention is a method of mitigating at least one symptom of a neuropsychiatric disorder, comprising administering to a subject in need thereof the lithium salt of an N-substituted glycine compound of Formula (I).
Public/Granted literature
- US20190008813A1 LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF Public/Granted day:2019-01-10
Information query
